Mandate

Vinge advises HealthCap in conjunction with its investment in Elsa Science

November 05, 2021 M&A

Vinge has advised HealthCap in conjunction with its investment in Elsa Science, which develops an app that provides patients suffering from rheumatoid arthritis to receive tailormade treatment.

The financing round is headed by Healthcap and also existing investors such as the Finnish venture capital company Inventure, Crowberry Capital from Iceland, Norrsken VC as well as Noaber from the Netherlands.

Vinge’s team primarily consisted of Johan WinnerbladStina BengtssonHannah Kajlinger and Lisa Hörnqvist.

Related

Vinge advises Summit Partners on its $1 billion-plus investment in Keyfactor

Vinge has, together with Kirkland & Ellis, advised Summit Partners in connection with a strategic growth investment in Keyfactor, a leader in trust infrastructure. The investment will help accelerate the company's global scale and growth initiatives, enabling product innovation, geographic expansion, team building and strategic acquisitions.
July 20, 2026

Vinge has advised VAROPreem in connection with its acquisition of Sunpine

Vinge has advised VAROPreem in connection with its acquisition of Sunpine from Sveaskog, Södra Skogsägarna and Lawter.
July 10, 2026